The Effect of Outcome Selection on the Performance of Prediction Models in Patients at Risk for Sepsis
Importance:. Risk prediction models for patients with suspected sepsis have been derived on and applied to various outcomes, including readily available outcomes such as hospital mortality and ICU admission as well as longer-term mortality outcomes that may be more important to patients. It is unkno...
Guardado en:
Autores principales: | Stephanie P. Taylor, MD, MS, Shih-Hsiung Chou, PhD, Andrew D. McWilliams, MD, MPH, Mark Russo, MD, Alan C. Heffner, MD, Stephanie Murphy, DO, Susan L. Evans, MD, FACS, FCCM, Whitney Rossman, MS, Marc Kowalkowski, PhD, on behalf of Acute Care Outcomes Research Network (ACORN) Investigators, Ryan Brown, Larry Burke, Shih-Hsiung Chou, Kyle Cunningham, Susan L. Evans, Scott Furney, Michael Gibbs, Alan Heffner, Timothy Hetherington, Daniel Howard, Marc Kowalkowski, Scott Lindblom, Andrea McCall, Lewis McCurdy, Andrew McWilliams, Stephanie Murphy, Alfred Papali, Christopher Polk, Whitney Rossman, Michael Runyon, Mark Russo, Melanie Spencer, Brice Taylor, Stephanie Taylor |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Wolters Kluwer
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/f02d5b96c37e49f685dad9fb517fbbe7 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Efficacy of Targeted Inhibitors in Metastatic Lung Squamous Cell Carcinoma With EGFR or ALK Alterations
por: Whitney E. Lewis, PharmD, et al.
Publicado: (2021) -
Eyelid Crease Height Affects the Evaluation of Age-related Changes in the Eyelids
por: Shinsuke Akita, MD, PhD, et al.
Publicado: (2021) -
MET Amplification and Efficacy of Nivolumab in Patients With NSCLC
por: Katsuhiro Yoshimura, MD, PhD, et al.
Publicado: (2021) -
A Pilot Double-Blind Placebo-Controlled Randomized Clinical Trial to Investigate the Effects of Early Enteral Nutrients in Sepsis
por: Faraaz Ali Shah, MD, MPH, et al.
Publicado: (2021) -
Conversion Surgery for Advanced Thoracic SMARCA4-Deficient Undifferentiated Tumor With Atezolizumab in Combination With Bevacizumab, Paclitaxel, and Carboplatin Treatment: A Case Report
por: Kei Kunimasa, MD, PhD, et al.
Publicado: (2021)